Athira Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $968 |
Gross Profit | -243 | -200 | -243 | 484 |
EBITDA | -6,503 | -6,766 | -8,900 | -15,323 |
EBIT | -6,611 | -6,966 | -9,143 | -15,566 |
Net Income | -6,611 | -6,966 | -9,143 | -15,003 |
Net Change In Cash | 0 | 0 | 0 | 968 |
Free Cash Flow | -4,668 | -6,999 | -14,665 | -26,013 |
Cash | 20,874 | 19,888 | 26,422 | 48,438 |
Basic Shares | 3,943 | 3,909 | 3,904 | 3,848 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -970 | -969 | -1,048 | -479 |
EBITDA | -95,805 | -125,968 | -88,010 | -54,371 |
EBIT | -96,775 | -126,937 | -88,855 | -54,850 |
Net Income | -96,940 | -117,672 | -95,639 | -54,853 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -14,151 | 49,912 | ||
Free Cash Flow | -97,203 | -101,057 | -73,610 | -44,671 |
Cash | 48,438 | 90,584 | 95,966 | 110,537 |
Basic Shares | 3,848 | 3,802 | 3,773 | 3,692 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.68 |
2025-06-30 | -$1.80 |
2025-03-31 | -$0.23 |
2024-12-31 | -$0.39 |
